Peter White



Tackling TB in the Age of Austerity: ensuring we use novel tools and approaches cost-effectively


Abstract: TB diagnoses in the UK remain high, having risen for two decades, and novel approaches to control are urgently needed. Limited resources mean interventions must be cost-effective, which requires effective targeting of both case-finding and support for treatment adherence. Assessing cost-effectiveness involves considering not just the benefits to individuals who are diagnosed and treated, but also calculation of how much transmission is averted by earlier treatment of active disease, or treatment of latent infection, which prevents active disease from occurring at all. We use mathematical modelling to evaluate novel approaches to finding patients, new diagnostics, and treatment approaches.

Mis à jour le 20/02/2014